Indolo[2,3-
d
]benzazepines (indololatonduines)
are rarely discussed in the literature. In this project, we prepared
a series of novel indololatonduine derivatives and their Ru
II
and Os
II
complexes and investigated their microtubule-targeting
properties in comparison with paclitaxel and colchicine. Compounds
were fully characterized by spectroscopic techniques (
1
H NMR and UV–vis), ESI mass-spectrometry, and X-ray crystallography,
and their purity was confirmed by elemental analysis. The stabilities
of the compounds in DMSO and water were confirmed by
1
H
and
13
C NMR and UV–vis spectroscopy. Novel indololatonduines
demonstrated anticancer activity
in vitro
in a low
micromolar concentration range, while their coordination to metal
centers resulted in a decrease of cytotoxicity. The preliminary
in vivo
activity of the Ru
II
complex was investigated.
Fluorescence staining and
in vitro
tubulin polymerization
assays revealed the prepared compounds to have excellent microtubule-destabilizing
activities, even more potent than the well-known microtubule-destabilizing
agent colchicine.